Targeting diphtheria toxin A-chain transcription to activated endothelial cells using an E-selectin promoter

Angiogenesis

Volumn 6, Issue 1, 2003, Pages 31-38

  Maxwell, Ian H ^a   Kaletta, Cortina ^b   Naujoks, Kurt ^b   Maxwell, Françoise ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b Munich Biotech AG   (Germany)

Author keywords

Diphtheria toxin; E selectin promoter; Endothelial cells; Transcription

Indexed keywords

DIPHTHERIA TOXIN; DIPHTHERIA TOXIN A; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; LUCIFERASE; TRANSCRIPTION FACTOR ETS 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL CULTURE; CONTROLLED STUDY; ELECTROPORATION; ENDOTHELIUM CELL; FIBROBLAST; GENE CONTROL; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REPORTER GENE; SEQUENCE ANALYSIS; SOLID TUMOR;

DIPHTHERIA TOXIN; E-SELECTIN; ENDOTHELIAL CELLS; GENES, REPORTER; HUMANS; PEPTIDE FRAGMENTS; PROMOTER REGIONS (GENETICS); TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 0142152639     PISSN: 09696970     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1025894616613     Document Type: Article

References (37)

1. Folkman J. Incipient angiogenesis. J Natl Cancer Inst 2000; 92: 94-5.
2. Novak K. Angiogenesis inhibitors revised and revived at AACR. Nat Med 2002; 8: 427.
3. Deplanque G, Harris AL. Anti-angiogenic agents: Clinical trial design and therapies in development. Eur J Cancer 2000; 36: 1713-24.
4. Pappenheimer AMJ. Diphtheria toxin. Ann Rev Biochem 1977; 46: 69-94.
5. Falnes PO, Ariansen S, Sandvig K, Olsnes S. Requirement for prolonged action in the cytosol for optimal protein synthesis inhibition by diphtheria toxin. J Biol Chem 2000; 275: 4363-68.
6. Kochi SK, Collier RJ. DNA fragmentation and cytolysis in U937 cells treated with diphtheria toxin or other inhibitors of protein synthesis. Exp Cell Res 1993; 208: 296-302.
7. Kageyama A, Kusano I, Tamura T et al. Comparison of the apoptosis-inducing abilities of various protein synthesis inhibitors in U937 cells. Biosci Biotechnol Biochem 2002; 66: 835-9.
8. Maxwell IH, Maxwell F, Glode LM. Regulated expression of a diphtheria toxin A-chain gene transfected into human cells: Possible strategy for inducing cancer cell suicide. Cancer Res 1986; 46: 4660-4.
9. Massuda ES, Dunphy EJ, Redman RA et al. Regulated expression of the diphtheria toxin A chain by a tumor-specific chimeric transcription factor results in selective toxicity for alveolar rhabdomyosarcoma cells. Proc Natl Acad Sci USA 1997; 94: 14701-6.
10. Palmiter RD, Behringer RR, Quaife CJ et al. Cell lineage ablation in transgenic mice by cell-specific expression of a toxin gene. Cell 1987; 50: 435-43.
11. Breitman ML, Clapoff S, Rossant J et al. Genetic ablation: Targeted expression of a toxin gene causes microphthalmia in transgenic mice. Science 1987; 238: 1563-5.
12. Burrows HL, Birkmeier TS, Seasholtz AF, Camper SA. Targeted ablation of cells in the pituitary primordia of transgenic mice. Mol Endocrinol 1996; 10: 1467-77.
13. Ying S, Jansen HT, Lehman MN et al. Retinal degeneration in cone photoreceptor cell-ablated transgenic mice. Mol Vis 2000; 24: 101-8.
14. Thurston G, McLean JW, Rizen M et al. Cationic liposomes target angiogenic endothelial cells in tumors and chronic inflammation in mice. J Clin Invest 1998; 101: 1401-13.
15. Augustin HG, Kozian DH, Johnson RC. Differentiation of endothelial cells: Analysis of the constitutive and activated endothelial cell phenotypes. Bioessays 1994; 16: 901-6.
16. Brooks PC, Clark RA, Cheresh DA. Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science 1994; 264: 569-71.
17. Harari OA, Wickham TJ, Stocker CJ et al. Targeting an adenoviral gene vector to cytokine-activated vascular endothelium via E-selectin. Gene Ther 1999; 6: 801-7.
18. Simon SI, Hu Y, Vestweber D, Smith CW. Neutrophil tethering on E-selectin activates beta 2 integrin binding to ICAM-1 through a mitogen-activated protein kinase signal transduction pathway. J Immunol 2000; 164: 4348-58.
19. Fox SB, Turner GD, Gatter KC, Harris AL. The increased expression of adhesion molecules ICAM-3, E- and P-selectins on breast cancer endothelium. J Pathol 1995; 177: 369-76.
20. Ye C, Kiriyama K, Mistuoka C et al. Expression of E-selectin on endothelial cells of small veins in human colorectal cancer. Int J Cancer 1995; 61: 455-60.
21. Walton T, Wang JL, Ribas A et al. Endothelium-specific expression of an E-selectin promoter recombinant adenoviral vector. Anticancer Res 1998; 18: 1357-60.
22. Murakami T, Mataki C, Nagao C et al. The gene expression profile of human umbilical vein endothelial cells stimulated by tumor necrosis factor alpha using DNA microarray analysis. J Atheroscler Thromb 2000; 7: 39-44.
23. Whitley MZ, Thanos D, Read MA et al. Striking similarity in the organization of the E-selectin and beta interferon gene promoters. Mol Cell Biol 1994; 14: 6464-75.
24. Maxwell IH, Harrison GS, Wood WM, Maxwell F. A DNA cassette containing a trimerized SV40 polyadenylation signal which efficiently blocks spurious plasmid-initiated transcription. Biotechniques 1989; 7: 276-80.
25. Day RN, Kawecki M, Berry D. Dual-function reporter protein for analysis of gene expression in living cells. Biotechniques 1998; 25: 848-56.
26. Schlaeger TM, Bartunkova S, Lawitts JA et al. Uniform vascular-endothelial-cell-specific gene expression in both embryonic and adult transgenic mice. Proc Natl Acad Sci USA 1997; 94: 3058-63.
27. Maxwell IH, Maxwell F. Electroporation of mammalian cells with a firefly luciferase expression plasmid: Kinetics of transient expression differ markedly among cell types. DNA 1988; 7: 557-62.
28. Duke RC, Cohen JJ. Quantitation of apoptotic index and cell viability using fluorescent dyes. Curr Protocols Immunol 1992; Suppl 3. 3.17.1.
29. Cotran RS, Gimbrone MA, Bevilacqua MP et al. Induction and detection of a human endothelial activation antigen in vivo. J Exp Med 1986; 164: 661-6.
30. Wang N, Chintala SK, Fini ME, Schuman JS. Activation of a tissue-specific stress response in the aqueous outflow pathway of the eye defines the glaucoma disease phenotype. Nat Med 2001; 7: 304-9.
31. Wernert N, Raes MB, Lassalle P et al. c-etsl proto-oncogene is a transcription factor expressed in endothelial cells during tumor vascularization and other forms of angiogenesis in humans. Am J Pathol 1992; 140: 119-27.
32. Li H, Oehrlein SA, Wallerath T et al. Activation of protein kinase C alpha and/or epsilon enhances transcription of the human endothelial nitric oxide synthase gene. Mol Pharmacol 1998; 53: 630-7.
33. Kunstfeld R, Wickenhauser G, Michaelis U et al. Paclitaxel encapsulated in cationic liposomes diminishes tumor angiogenesis and melanoma growth in a 'humanized' SCID mouse model. J Invest Dermatol 2003; 120: 476-82.
34. McLean JW, Fox EA, Baluk P et al. Organ-specific endothelial cell uptake of cationic liposome-DNA complexes in mice. Am J Physiol 1997; 273: H387-404.
35. Arap W, Pasqualini R, Ruoslahti E. Chemotherapy targeted to tumor vasculature. Curr Opin Oncol 1998; 10: 560-5.
36. Maxwell F, Maxwell IH, Glode LM. Cloning, sequence determination, and expression in transfected cells of the coding sequence for the tox176 attenuated diphtheria toxin A chain. Mol Cell Biol 1987; 7: 1576-79.
37. Hood JD, Bednarski M, Frausto R et al. Tumor regression by targeted gene delivery to the neovasculature. Science 2002; 296: 2404-7.